Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,425 | 190 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,248 | 60 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $658.55 | 53 | $0 (2024) |
| GENZYME CORPORATION | $410.91 | 22 | $0 (2024) |
| QOL Medical, LLC | $288.48 | 15 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $275.07 | 13 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $116.29 | 6 | $0 (2023) |
| Daiichi Sankyo Inc. | $104.77 | 5 | $0 (2024) |
| Gilead Sciences, Inc. | $100.57 | 3 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $59.01 | 4 | $0 (2023) |
| Intercept Pharmaceuticals, Inc. | $51.89 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,769 | 100 | ABBVIE INC. ($765.16) |
| 2023 | $606.25 | 27 | ABBVIE INC. ($328.68) |
| 2022 | $414.45 | 20 | GENZYME CORPORATION ($168.90) |
| 2021 | $635.61 | 43 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($354.81) |
All Payment Transactions
190 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Gastroenterology | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: Gastroenterology | ||||||
| 12/19/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.93 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: LIVER DISEASE | ||||||
| 12/11/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $8.19 | General |
| Category: Immunology | ||||||
| 12/02/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $17.51 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/25/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Gastroenterology | ||||||
| 11/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $8.79 | General |
| Category: Immunology | ||||||
| 11/11/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $7.88 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $21.46 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.89 | General |
| Category: Gastroenterology | ||||||
| 10/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/28/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $20.12 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 69 | 71 | $12,947 | $5,759 |
| 2022 | 2 | 86 | 90 | $18,150 | $7,871 |
| 2021 | 3 | 153 | 199 | $38,734 | $15,660 |
| 2020 | 2 | 71 | 76 | $12,880 | $5,337 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 47 | 49 | $8,085 | $3,238 | 40.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 22 | $4,862 | $2,521 | 51.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 64 | 68 | $11,220 | $5,577 | 49.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $6,930 | $2,294 | 33.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 91 | 118 | $19,470 | $9,215 | 47.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 34 | 34 | $10,710 | $3,275 | 30.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 28 | 47 | $8,554 | $3,170 | 37.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 52 | 56 | $9,240 | $3,971 | 43.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 19 | 20 | $3,640 | $1,366 | 37.5% |
About Allison Rublaitus
Allison Rublaitus is a Family healthcare provider based in Sylvania, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/27/2019. The National Provider Identifier (NPI) number assigned to this provider is 1609412436.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Allison Rublaitus has received a total of $3,425 in payments from pharmaceutical and medical device companies, with $1,769 received in 2024. These payments were reported across 190 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($3,425).
As a Medicare-enrolled provider, Rublaitus has provided services to 379 Medicare beneficiaries, totaling 436 services with total Medicare billing of $34,628. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Sylvania, OH
- Active Since 11/27/2019
- Last Updated 11/03/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1609412436
Products in Payments
- RINVOQ (Biological) $498.44
- DUPIXENT (Biological) $469.92
- XIFAXAN (Drug) $432.99
- MAVYRET (Drug) $245.70
- SUCRAID (Drug) $237.23
- TRULANCE (Drug) $225.56
- SKYRIZI (Biological) $211.89
- ENTYVIO (Biological) $207.10
- CREON (Drug) $158.98
- ZENPEP (Drug) $133.12
- INJECTAFER (Drug) $104.77
- Epclusa (Drug) $70.76
- EOHILIA (Drug) $60.39
- VIBERZI (Drug) $56.11
- OCALIVA (Drug) $51.89
- Sucraid (Drug) $51.25
- HUMIRA (Biological) $43.42
- LINZESS (Drug) $33.24
- RESMETIROM (Drug) $26.30
- IQIRVO (Drug) $19.83
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Sylvania
Kelsey Cutcher
Family — Payments: $7,098
Stacie Kregel, Cnp, CNP
Family — Payments: $5,813
Mindy Howard, Fnp, FNP
Family — Payments: $4,394
Rachel Baker, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $3,878
Amy Butler, Aprn, Cnp, APRN, CNP
Family — Payments: $2,086
Kendra Watts, Cnp, CNP
Family — Payments: $2,055